Results 1 to 10 of about 24,849,647 (427)
Artificial Intelligence in Cancer Research: Trends, Challenges and Future Directions
Life, 2022The World Health Organization (WHO), in their 2022 report, identified cancer as one of the leading causes of death, accounting for about 16% of deaths worldwide.
Anu Maria Sebastian, David Peter
doaj +2 more sources
Ca-A Cancer Journal for Clinicians, 2021
This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer.
Hyuna Sung+2 more
exaly +2 more sources
This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer.
Hyuna Sung+2 more
exaly +2 more sources
Metabolomics in cancer research and emerging applications in clinical oncology
Ca-A Cancer Journal for Clinicians, 2021Cancer has myriad effects on metabolism that include both rewiring of intracellular metabolism to enable cancer cells to proliferate inappropriately and adapt to the tumor microenvironment, and changes in normal tissue metabolism.
Daniel R Schmidt+2 more
exaly +2 more sources
Microfluidic Technologies in Advancing Cancer Research [PDF]
MicromachinesThis review explores the significant role of microfluidic technologies in advancing cancer research, focusing on the below key areas: droplet-based microfluidics, organ-on-chip systems, paper-based microfluidics, electrokinetic chips, and microfluidic ...
Arjun Ajikumar, Kin Fong Lei
doaj +2 more sources
Ca-A Cancer Journal for Clinicians, 2018
This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across ...
Freddie Bray+2 more
exaly +2 more sources
This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across ...
Freddie Bray+2 more
exaly +2 more sources
How prevalent is a cancer-protective lifestyle? Adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations in Switzerland. [PDF]
, 2022Population monitoring of lifestyle behaviors that are crucial as risk and protective factors for major chronic diseases is vital for the identification of priority areas for public health.
Karavasiloglou, Nena+5 more
core +1 more source
Spatial omics: Navigating to the golden era of cancer research
Clinical and Translational Medicine, 2022The idea that tumour microenvironment (TME) is organised in a spatial manner will not surprise many cancer biologists; however, systematically capturing spatial architecture of TME is still not possible until recent decade.
Yingcheng Wu+4 more
semanticscholar +1 more source
Building capacity for clinical research in developing countries: the INDOX cancer research network experience [PDF]
Global Health Action, 2012Transnational Organisations increasingly prioritise the need to support local research capacity in low and middle income countries in order that local priorities are addressed with due consideration of contextual issues. There remains limited evidence on
Raghib Ali+2 more
doaj +1 more source
Applications of Microfluidics and Organ-on-a-Chip in Cancer Research
Biosensors, 2022Taking the life of nearly 10 million people annually, cancer has become one of the major causes of mortality worldwide and a hot topic for researchers to find innovative approaches to demystify the disease and drug development.
Sagar Regmi+3 more
semanticscholar +1 more source
Cancer Innovation, 2022
Phosphoinositide 3‐kinase (PI3K)/protein kinase B (PKB or AKT)/mammalian target of rapamycin (mTOR) signaling pathway (PAM pathway) plays an important role in the development of breast cancer and are closely associated with the resistance to endocrine ...
The Society of Clinical Research of Oncology Medications of China Anticancer Association+2 more
doaj +1 more source
Phosphoinositide 3‐kinase (PI3K)/protein kinase B (PKB or AKT)/mammalian target of rapamycin (mTOR) signaling pathway (PAM pathway) plays an important role in the development of breast cancer and are closely associated with the resistance to endocrine ...
The Society of Clinical Research of Oncology Medications of China Anticancer Association+2 more
doaj +1 more source